日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Maturase K (matK), partial CSB-YP822072NHB
CSB-EP822072NHB
CSB-BP822072NHB
CSB-MP822072NHB
CSB-EP822072NHB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Kokia drynarioides Maturase K (matK), partial CSB-YP822073KAAI
CSB-EP822073KAAI
CSB-BP822073KAAI
CSB-MP822073KAAI
CSB-EP822073KAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hedera helix Translation initiation factor IF-1, chloroplastic (infA) CSB-YP822074HCJ
CSB-EP822074HCJ
CSB-BP822074HCJ
CSB-MP822074HCJ
CSB-EP822074HCJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Translation initiation factor IF-1, chloroplastic (infA) CSB-YP822075AIQ
CSB-EP822075AIQ
CSB-BP822075AIQ
CSB-MP822075AIQ
CSB-EP822075AIQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Triticum aestivum NAD (P)H-quinone oxidoreductase subunit 5, chloroplastic (ndhF), partial CSB-YP822076TQN
CSB-EP822076TQN
CSB-BP822076TQN
CSB-MP822076TQN
CSB-EP822076TQN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Triticum aestivum 30S ribosomal protein S18, chloroplastic (rps18) CSB-YP822077TQN
CSB-EP822077TQN
CSB-BP822077TQN
CSB-MP822077TQN
CSB-EP822077TQN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pan troglodytes Patr class I histocompatibility antigen, alpha chain E (Patr-E), partial CSB-YP822078EQV
CSB-EP822078EQV
CSB-BP822078EQV
CSB-MP822078EQV
CSB-EP822078EQV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis BTB/POZ domain-containing protein 16 (BTBD16), partial CSB-YP822079MOV
CSB-EP822079MOV
CSB-BP822079MOV
CSB-MP822079MOV
CSB-EP822079MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Growth/differentiation factor 8 (MSTN) CSB-YP822080MOV
CSB-EP822080MOV
CSB-BP822080MOV
CSB-MP822080MOV
CSB-EP822080MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pig Arginase-1 (ARG1) CSB-YP822081PI
CSB-EP822081PI
CSB-BP822081PI
CSB-MP822081PI
CSB-EP822081PI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorocebus aethiops DnaJ homolog subfamily A member 1 (DNAJA1) CSB-YP822082DSU
CSB-EP822082DSU
CSB-BP822082DSU
CSB-MP822082DSU
CSB-EP822082DSU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Cation channel sperm-associated protein subunit delta (CATSPERD), partial CSB-YP822083MOV
CSB-EP822083MOV
CSB-BP822083MOV
CSB-MP822083MOV
CSB-EP822083MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Coiled-coil domain-containing protein 67 (CCDC67), partial CSB-YP822084MOV
CSB-EP822084MOV
CSB-BP822084MOV
CSB-MP822084MOV
CSB-EP822084MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Uncharacterized protein C9orf43 homolog (QtsA-15013) CSB-YP822085MOV
CSB-EP822085MOV
CSB-BP822085MOV
CSB-MP822085MOV
CSB-EP822085MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Uncharacterized protein C20orf152 homolog (QtsA-11192, QtsA-13521), partial CSB-YP822086MOV
CSB-EP822086MOV
CSB-BP822086MOV
CSB-MP822086MOV
CSB-EP822086MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis E3 ubiquitin-protein ligase RNF133 (RNF133), partial CSB-YP822087MOV1
CSB-EP822087MOV1
CSB-BP822087MOV1
CSB-MP822087MOV1
CSB-EP822087MOV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Protection of telomeres protein 1 (POT1), partial CSB-YP822088MOV
CSB-EP822088MOV
CSB-BP822088MOV
CSB-MP822088MOV
CSB-EP822088MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis PILR-associating neural protein (QccE-10858, QtrA-14178), partial CSB-YP822089MOV
CSB-EP822089MOV
CSB-BP822089MOV
CSB-MP822089MOV
CSB-EP822089MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis UDP-xylose and UDP-N-acetylglucosamine transporter (SLC35B4), partial CSB-YP822090MOV
CSB-EP822090MOV
CSB-BP822090MOV
CSB-MP822090MOV
CSB-EP822090MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Vesicular inhibitory amino acid transporter (SLC32A1), partial CSB-YP822091MOV
CSB-EP822091MOV
CSB-BP822091MOV
CSB-MP822091MOV
CSB-EP822091MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細(xì)胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×